朗格汉斯细胞在特应性皮炎中的研究进展

doi:10.35541/cjd.20220279

中华皮肤科杂志 ›› 2023, e20220279.doi: 10.35541/cjd.20220279

朗格汉斯细胞在特应性皮炎中的研究进展

陈锦丛¹ 林立航¹ 苏惠春^1，2

¹福建医科大学附属协和医院皮肤科，福州 350001；²福建医科大学附属第一医院皮肤科，福州 350004

收稿日期:2022-04-22 修回日期:2022-10-09 发布日期:2023-07-12
通讯作者: 林立航；苏惠春 E-mail:460879404@qq.com; suhuichun@163.com
基金资助:
福建省自然科学基金;福建医科大学附属协和医院引进人才启动基金

Roles of Langerhans cells in atopic dermatitis

Chen Jincong¹, Lin Lihang¹, Su Huichun^1,2

Received:2022-04-22 Revised:2022-10-09 Published:2023-07-12
Contact: Lin Lihang; Su Huichun E-mail:460879404@qq.com; suhuichun@163.com
Supported by:
Natural Science Foundation of Fujian Province of China;The Investigator Initiation Fund Project of Fujian Medical University Union Hospital

摘要/Abstract

摘要： 【摘要】朗格汉斯细胞（LC）是表皮中重要的抗原呈递细胞，分为稳态、激活态和LC样细胞。特应性皮炎（AD）是一种慢性复发性炎症性疾病。最新的研究显示，LC在AD的不同年龄分期、瘙痒、皮损愈合等方面也发挥着重要作用。另外，在AD不同微环境下，不同亚群的LC和LC样细胞通过激活或抑制不同的分子开关和炎症通路发挥促进或抑制AD炎症的作用。

关键词: 朗格尔汉斯细胞, 皮炎, 特应性, 瘙痒症, 年龄因素, 伤口愈合

Abstract: 【Abstract】 Langerhans cells（LCs） are a kind of important antigen-presenting cells in the epidermis, and are usually divided into 3 subsets: steady-state, activated, and LC-like cells. Atopic dermatitis（AD） is a chronic recurrent inflammatory disease. The latest studies have shown that LCs play important roles in different age stages, pruritus, skin lesion healing, and other aspects in AD. In addition, in different microenvironments of AD, different subpopulations of LCs and LC-like cells play contradictory roles in promoting or inhibiting the inflammation in AD by activating or inhibiting different molecular switches and inflammatory pathways.

Key words: Langerhans cell, Dermatitis, atopic, Pruritus, Age factors, Wound healing

陈锦丛林立航苏惠春. 朗格汉斯细胞在特应性皮炎中的研究进展[J]. 中华皮肤科杂志, 2023,e20220279. doi:10.35541/cjd.20220279

Chen Jincong, Lin Lihang, Su Huichun, . Roles of Langerhans cells in atopic dermatitis[J]. Chinese Journal of Dermatology,2023,e20220279. doi:10.35541/cjd.20220279

参考文献 35

［1］	Liu X, Zhu R, Luo Y, et al. Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation［J］. Immunity, 2021,54（10）:2305⁃2320.e11. doi: 10.1016/j.immuni.2021.08.012.
［2］	Sheng J, Chen Q, Wu X, et al. Fate mapping analysis reveals a novel murine dermal migratory Langerhans⁃like cell population［J］. Elife, 2021,10. doi: 10.7554/eLife.65412.
［3］	Girolomoni G, Busà V M. Flare management in atopic dermatitis: from definition to treatment［J］. Ther Adv Chronic Dis, 2022,13:364115304.doi: 10.1177/20406223211066728.
［4］	Zhang S, Edwards TN, Chaudhri VK, et al. Nonpeptidergic neurons suppress mast cells via glutamate to maintain skin homeostasis［J］. Cell, 2021,184（8）:2151⁃2166. doi: 10.1016/j.cell.2021.03.002.
［5］	Becerril⁃García M A, Yam⁃Puc J C, Maqueda⁃Alfaro R, et al. Langerhans cells from mice at birth express endocytic⁃ and pattern recognition⁃receptors, migrate to draining lymph nodes ferrying antigen and activate neonatal T cells in vivo［J］. Front Immunol, 2020,11:744. doi: 10.3389/fimmu.2020.00744.
［6］	Brough HA, Nadeau KC, Sindher SB, et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented?［J］. Allergy, 2020,75（9）:2185⁃2205. doi: 10.1111/all.14304.
［7］	Fania L, Moretta G, Antonelli F, et al. Multiple roles for cytokines in atopic dermatitis: from pathogenic mediators to endotype⁃specific biomarkers to therapeutic targets［J］. Int J Mol Sci, 2022,23（5）. doi: 10.3390/ijms23052684.
［8］	Matsui K, Shibata R, Mogi K. Influence of the Th1 cytokine environment on CCL5 production from Langerhans cells［J］. Biol Pharm Bull, 2022,45（4）:491⁃496. doi: 10.1248/bpb.b21⁃00985.
［9］	Pilkington SM, Ogden S, Eaton LH, et al. Lower levels of interleukin⁃1β gene expression are associated with impaired Langerhans′ cell migration in aged human skin［J］. Immunology, 2018,153（1）:60⁃70. doi: 10.1111/imm.12810.
［10］	Hasegawa T, Feng Z, Yan Z, et al. Reduction in human epidermal Langerhans cells with age is associated with decline in CXCL14⁃mediated recruitment of CD14（+） monocytes［J］. J Invest Dermatol, 2020,140（7）:1327⁃1334. doi: 10.1016/j.jid.2019.11.017.
［11］	唐玉祺, 刘双飞, 杨泽安, 等. 老年特应性皮炎的诊疗研究进展［J］. 皮肤性病诊疗学杂志, 2021,28（5）:411⁃414. doi: 10. 3969/j.issn.1674－8468.2021.05.018.
［12］	Tang L, Li X, Deng Z, et al. Conjugated linoleic acid attenuates 2,4⁃dinitrofluorobenzene⁃induced atopic dermatitis in mice through dual inhibition of COX⁃2/5⁃LOX and TLR4/NF⁃κB signaling［J］. J Nutr Biochem, 2020,81:108379.doi: 10.1016/j.jnutbio.2020.108379.
［13］	Rajesh A, Wise L, Hibma M. The role of Langerhans cells in pathologies of the skin［J］. Immunol Cell Biol, 2019,97（8）:700⁃713. doi: 10.1111/imcb.12253.
［14］	Miake S, Tsuji G, Takemura M, et al. IL⁃4 augments IL⁃31/IL⁃31 receptor alpha interaction leading to enhanced Ccl 17 and Ccl 22 production in dendritic cells: implications for atopic dermatitis［J］. Int J Mol Sci, 2019,20（16）:4053. doi: 10.3390/ijms2016 4053.
［15］	Cevikbas F, Lerner EA. Physiology and pathophysiology of itch［J］. Physiol Rev, 2020,100（3）:945⁃982. doi: 10.1152/physrev. 00017.2019.
［16］	Yosipovitch G, Berger T, Fassett MS. Neuroimmune interactions in chronic itch of atopic dermatitis［J］. J Eur Acad Dermatol Venereol, 2020,34（2）:239⁃250. doi: 10.1111/jdv.15973.
［17］	Pavel P, Blunder S, Moosbrugger⁃Martinz V, et al. Atopic dermatitis: the fate of the fat［J］. Int J Mol Sci, 2022,23（4）.doi: 10.3390/ijms23042121.
［18］	Szöllősi AG, Oláh A, Lisztes E, et al. Pruritus: a sensory symptom generated in cutaneous immuno⁃neuronal crosstalk［J］. Front Pharmacol, 2022,13:745658. doi: 10.3389/fphar.2022. 745658.
［19］	Deckers J, Hammad H, Hoste E. Langerhans cells: sensing the environment in health and disease［J］. Front Immunol, 2018,9:93. doi: 10.3389/fimmu.2018.00093.
［20］	Ledwon JK, Vaca EE, Huang CC, et al. Langerhans cells and SFRP2/Wnt/beta⁃catenin signalling control adaptation of skin epidermis to mechanical stretching［J］. J Cell Mol Med, 2022,26（3）:764⁃775. doi: 10.1111/jcmm.17111.
［21］	Rajesh A, Stuart G, Real N, et al. Depletion of langerin（+） cells enhances cutaneous wound healing［J］. Immunology, 2020,160（4）:366⁃381. doi: 10.1111/imm.13202.
［22］	Esser⁃von Bieren J. Eicosanoids in tissue repair［J］. Immunol Cell Biol, 2019,97（3）:279⁃288. doi: 10.1111/imcb. 12226.
［23］	Otsuka M, Egawa G, Kabashima K. Uncovering the mysteries of Langerhans cells, inflammatory dendritic epidermal cells, and monocyte⁃derived Langerhans cell⁃like cells in the epidermis［J］. Front Immunol, 2018,9:1768. doi: 10.3389/fimmu.2018. 01768.
［24］	Egawa G, Kabashima K. A new player in the dermis［J］. Elife 2021,10:e68979. doi: 10.7554/eLife.68979.
［25］	Park HH, Lee S, Yu Y, et al. TGF⁃β secreted by human umbilical cord blood⁃derived mesenchymal stem cells ameliorates atopic dermatitis by inhibiting secretion of TNF⁃α and IgE［J］. Stem cells, 2020,38（7）:904⁃916. doi: 10.1002/stem.3183.
［26］	Strobl H, Krump C, Borek I. Micro⁃environmental signals directing human epidermal Langerhans cell differentiation［J］. Semin Cell Dev Biol, 2019,86:36⁃43. doi: 10.1016/j.semcdb. 2018.02.016.
［27］	Sconocchia T, Del Gaudio I, Meshcheryakova A, et al. Induction of the sphingosine⁃1⁃phosphate signaling pathway by TGF⁃β1 during Langerhans⁃type dendritic cell differentiation［J］. Eur J Immunol, 2021,51（7）:1854⁃1856. doi: 10.1002/eji.202049013.
［28］	Brand A, Diener N, Zahner SP, et al. E⁃cadherin is dispensable to maintain Langerhans cells in the epidermis［J］. J Invest Dermatol, 2020,140（1）:132⁃142. doi: 10.1016/j.jid.2019.06.132.
［29］	Turner CT, Zeglinski MR, Richardson KC, et al. Granzyme B contributes to barrier dysfunction in oxazolone⁃induced skin inflammation through E⁃cadherin and FLG cleavage［J］. J Invest Dermatol, 2021,141（1）: 36⁃47. doi: 10.1016/j.jid.2020.05.095.
［30］	Yeo H, Ahn SS, Lee JY, et al. Disrupting the DNA binding of egr⁃1 with a small⁃molecule inhibitor ameliorates 2,4⁃dinitrochlorobenzene⁃induced skin inflammation［J］. J Invest Dermatol, 2021,141（7）:1851⁃1855. doi: 10.1016/j.jid.2020.12. 029.
［31］	Gratton R, Tricarico PM, Moltrasio C, et al. Pleiotropic role of Notch signaling in human skin diseases［J］. Int J Mol Sci, 2020,21（12）. doi: 10.3390/ijms21124214.
［32］	Marschall P, Wei R, Segaud J, et al. Dual function of Langerhans cells in skin TSLP⁃promoted T（FH） differentiation in mouse atopic dermatitis［J］. J Allergy Clin Immunol, 2021,147（5）:1778⁃1794. doi: 10.1016/j.jaci. 2020.10.006.
［33］	Davies J, Vallejo AF, Sirvent S, et al. An IRF1⁃IRF4 toggle⁃switch controls tolerogenic and immunogenic transcriptional programming in human Langerhans cells［J］. Front Immunol, 2021,12:665312. doi: 10.3389/fimmu. 2021.665312.
［34］	Yu J, Luo Y, Zhu Z, et al. A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor［J］. J Allergy Clin Immunol, 2019,143（6）:2108⁃2119. doi: 10.1016/j.jaci.2018. 11.036.
［35］	Hong C, Lin S, Clausen BE, et al. Selective AhR knockout in langerin⁃expressing cells abates Langerhans cells and polarizes Th2/Tr1 in epicutaneous protein sensitization［J］. Proc Natl Acad Sci U S A, 2020,117（23）:12980⁃12990. doi: 10.1073/pnas.1917479117.

[1]	肖星王珊杨欢舒虹郭艳萍陈谨萍路遥李钦峰梁源赵牧童罗晓燕缪丽敏徐锐李雪梅赖沙李建红罗珍喻泸邢璐王美潭黎晓丽徐海涛李萍王华马琳. 多中心随机对照临床试验观察2%克立硼罗软膏与1%吡美莫司乳膏治疗儿童轻中度特应性皮炎的疗效和安全性[J]. 中华皮肤科杂志, 2025, 58(5): 425-430.
[2]	中华医学会皮肤性病学分会儿童学组中华医学会儿科学分会皮肤性病学组中国康复医学会皮肤病康复专业委员会中国医师协会皮肤科医师分会儿童皮肤病学组. [开放获取] 中国儿童特应性皮炎专病门诊建设及标准化病案管理专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 0(4): 20240338-e20240338.
[3]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. [开放获取] 特应性皮炎达标门诊建设标准专家共识（2025基层版）[J]. 中华皮肤科杂志, 2025, 0(4): 20240296-e20240296.
[4]	陈良宏孙艳王敬玉吴严. 本维莫德在皮肤病中的研究进展[J]. 中华皮肤科杂志, 2025, 58(3): 266-268.
[5]	李明李妍李邻峰. Janus激酶抑制剂在中重度特应性皮炎中的应用进展[J]. 中华皮肤科杂志, 2025, 0(3): 20220342-e0220342.
[6]	许焯红胡煜顾恒. 间充质干细胞来源的外泌体在皮肤病中的作用[J]. 中华皮肤科杂志, 2025, 0(3): 20220881-e20220881.
[7]	叶慧邓仕琳梁景耀张锡宝. 特应性皮炎复发控制与组织驻留记忆性T细胞的相关性研究进展[J]. 中华皮肤科杂志, 2025, 0(3): 20240192-e20240192.
[8]	张蓓蕾宋秀祖. 敏感性头皮的病因与发病机制[J]. 中华皮肤科杂志, 2025, 0(3): 20240301-e20240301.
[9]	黄晓燕粟娟陈明亮陈翔肖易沈敏学. 纳洛酮改善慢性砷暴露相关瘙痒人群健康相关生活质量的效果：一项随机、双盲、安慰剂对照试验[J]. 中华皮肤科杂志, 2025, 58(2): 161-166.
[10]	刘雅妮赵倩刘源张俊艳王惠平. 特应性皮炎控制工具评估病情控制情况的有效性验证[J]. 中华皮肤科杂志, 2025, 58(2): 154-160.
[11]	李安琪孙秋宁. 脑源性神经营养因子与皮肤病[J]. 中华皮肤科杂志, 2025, 58(2): 190-193.
[12]	中国康复医学会皮肤病康复专业委员会中国中西医结合学会皮肤性病专业委员会老年皮肤病学组. [开放获取] 老年皮肤瘙痒症诊疗与康复专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(1): 1-8.
[13]	王博郑捷. 老年银屑病和特应性皮炎患者生物制剂及小分子药物治疗中应注意的问题[J]. 中华皮肤科杂志, 2025, 58(1): 72-75.
[14]	杨子靖陈利红阮叶平文莞廷张嘉艺王海伦潘萌赵肖庆. 度普利尤单抗治疗老年性特应性皮炎的疗效及安全性研究[J]. 中华皮肤科杂志, 2025, 58(1): 65-69.
[15]	王迪张瑞珺康玉英. 脂溢性皮炎的发病机制及治疗研究进展[J]. 中华皮肤科杂志, 2025, 58(1): 89-92.

朗格汉斯细胞在特应性皮炎中的研究进展

Roles of Langerhans cells in atopic dermatitis

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 35

相关文章 15

Metrics

本文评价

推荐阅读 10